Compare CWH & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CWH | ELVN |
|---|---|---|
| Founded | 1966 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2016 | 2020 |
| Metric | CWH | ELVN |
|---|---|---|
| Price | $10.32 | $16.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | $18.11 | ★ $41.20 |
| AVG Volume (30 Days) | ★ 1.9M | 661.3K |
| Earning Date | 10-28-2025 | 11-12-2025 |
| Dividend Yield | ★ 4.83% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $6,400,054,000.00 | N/A |
| Revenue This Year | $5.30 | N/A |
| Revenue Next Year | $5.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.58 | N/A |
| 52 Week Low | $9.49 | $13.30 |
| 52 Week High | $24.37 | $25.37 |
| Indicator | CWH | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 36.89 | 33.61 |
| Support Level | $10.12 | $17.31 |
| Resistance Level | $11.05 | $20.47 |
| Average True Range (ATR) | 0.55 | 1.39 |
| MACD | 0.09 | -0.41 |
| Stochastic Oscillator | 9.44 | 6.66 |
Camping World Holdings Inc is a retailer of RVs and related products and services. The company has two reportable segments; the Good Sam Services and Plans segment, which includes the sale of emergency roadside assistance plans; commissions on property and casualty insurance programs; travel assist programs; extended vehicle service contracts; vehicle financing and refinancing assistance; consumer shows and events; and consumer publications and directories; and the RV and Outdoor Retail segment, which generates maximum revenue and includes the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, business to business distribution of RV furniture, etc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.